Will Doctors Soon Prescribe Ecstasy?
Altered States
00:00
Challenges in Blinding and Regulation of Psychoactive Drug Trials
This chapter explores the intricacies of double-blind clinical trials for psychoactive drugs, particularly MDMA. It highlights the challenges of blinding in trials and the regulatory hurdles imposed by the FDA in managing MDMA-assisted therapy.
Transcript
Play full episode
